Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0YVBCV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
REGN-3124-PBD
|
|||||
| Synonyms |
REGN 3124 PBD; REGN3124-PBD
Click to Show/Hide
|
|||||
| Organization |
Regeneron Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Glioblastoma [ICD11:2A00]
Clinical candidate
|
|||||
| Structure |
|
|||||
| Antibody Name |
REGN3124
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor variant III (EGFRvIII)
|
Antigen Info | ||||
| Payload Name |
SG3199
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Mal-PEG8-Val-Ala-PABC
|
Linker Info | ||||
| Conjugate Type |
Inter-chain cysteine.
|
|||||
| Combination Type |
SG3249
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.